Altimmune

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Altimmune and other ETFs, options, and stocks.

About ALT

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. 

CEO
Jerome B. Durso
CEOJerome B. Durso
Employees
57
Employees57
Headquarters
Gaithersburg, Maryland
HeadquartersGaithersburg, Maryland
Founded
1997
Founded1997
Employees
57
Employees57

ALT Key Statistics

Market cap
567.86M
Market cap567.86M
Price-Earnings ratio
-2.88
Price-Earnings ratio-2.88
Dividend yield
Dividend yield
Average volume
3.90M
Average volume3.90M
High today
$3.05
High today$3.05
Low today
$2.77
Low today$2.77
Open price
$2.83
Open price$2.83
Volume
5.77M
Volume5.77M
52 Week high
$7.73
52 Week high$7.73
52 Week low
$2.56
52 Week low$2.56

Stock Snapshot

With a market cap of 567.86M, Altimmune(ALT) trades at $2.95. The stock has a price-to-earnings ratio of -2.88.

On 2026-06-22, Altimmune(ALT) stock moved within a range of $2.77 to $3.05. With shares now at $2.95, the stock is trading +6.5% above its intraday low and -3.1% below the session's peak.

Trading activity shows a volume of 5.77M, compared to an average daily volume of 3.9M.

The stock's 52-week range extends from a low of $2.56 to a high of $7.73.

The stock's 52-week range extends from a low of $2.56 to a high of $7.73.

ALT News

Investing.com 12h
Leerink initiates Altimmune stock coverage citing liver drug data - Investing.com

...

Leerink initiates Altimmune stock coverage citing liver drug data - Investing.com
TipRanks 12h
Altimmune initiated with an Outperform at Leerink

Leerink analyst Thomas Smith initiated coverage of Altimmune (ALT) with an Outperform rating and $10 price target Altimunne is an attractive play in an increasi...

Analyst ratings

82%

of 11 ratings
Buy
81.8%
Hold
18.2%
Sell
0%

People also own

Based on the portfolios of people who own ALT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.